brl 42810 has been researched along with Disease Models, Animal in 13 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BAY 57-1293 represents a new class of potent inhibitors of herpes simplex virus (HSV) that target the virus helicase primase complex." | 7.74 | The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1. ( Biswas, S; Field, HJ; Jennens, L, 2007) |
| "BAY 57-1293 represents a new class of potent inhibitors of herpes simplex virus (HSV) that target the virus helicase primase complex." | 3.74 | The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1. ( Biswas, S; Field, HJ; Jennens, L, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Komoto, S | 1 |
| Higaki, S | 2 |
| Fukuda, M | 1 |
| Shimomura, Y | 1 |
| Biswas, S | 1 |
| Jennens, L | 1 |
| Field, HJ | 4 |
| Tsiquaye, KN | 1 |
| Slomka, MJ | 1 |
| Maung, M | 1 |
| Thackray, AM | 3 |
| Wutzler, P | 1 |
| Ulbricht, A | 1 |
| Färber, I | 1 |
| Main, J | 1 |
| McCarron, B | 1 |
| Thomas, HC | 1 |
| Korba, BE | 1 |
| Cote, P | 1 |
| Hornbuckle, W | 1 |
| Schinazi, R | 1 |
| Gerin, JL | 1 |
| Tennant, BC | 1 |
| Loutsch, JM | 1 |
| Sainz, B | 1 |
| Marquart, ME | 1 |
| Zheng, X | 1 |
| Kesavan, P | 1 |
| Hill, JM | 1 |
| Tal-Singer, R | 1 |
| Chen, Y | 1 |
| Guo, S | 1 |
| Qi, Z | 1 |
| Huang, A | 1 |
| Sohn, S | 1 |
| Bang, D | 1 |
| Lee, ES | 1 |
| Kwon, HJ | 1 |
| Lee, SI | 1 |
| Lee, S | 1 |
| Shaw, MM | 1 |
| Gürr, WK | 1 |
| Watts, PA | 1 |
| Littler, E | 1 |
1 review available for brl 42810 and Disease Models, Animal
| Article | Year |
|---|---|
Treatment of chronic viral hepatitis.
Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models | 1998 |
12 other studies available for brl 42810 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Effects of antiviral medications on herpetic epithelial keratitis in mice.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Animals; Antiviral Agents; | 2015 |
The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
Topics: 2-Aminopurine; Administration, Oral; Animals; Antiviral Agents; Brain Stem; Disease Models, Animal; | 2007 |
Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Animals; Animals, Newborn; Antiviral Agents; Biotran | 1994 |
Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
Topics: 2-Aminopurine; Acute Disease; Acyclovir; Animals; Antiviral Agents; Brain Stem; Disease Models, Anim | 1996 |
Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice.
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Disease Models, A | 1997 |
Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Disease Models, Animal; Famciclovir; Herpes Sim | 2000 |
Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Carrier State; Disease Models, Animal; Drug Therapy, Combi | 2000 |
Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
Topics: 2-Aminopurine; Acute Disease; Administration, Oral; Administration, Topical; Animals; Antiviral Agen | 2001 |
[Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
Topics: 2-Aminopurine; Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Drug Therapy, Combinat | 2001 |
Experimental studies on the antiviral agent famciclovir in Behçet's disease symptoms in ICR mice.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Behcet Syndrome; Disease Models, Animal; Famciclovir; Herp | 2001 |
Temporal pattern of herpes simplex virus type 1 infection and cell death in the mouse brain stem: influence of guanosine nucleoside analogues.
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Apoptosis; Brain Stem; Disease Models, Animal; | 2002 |